25 [OH] Vitamin D and Intact Parathyroid Hormone in Congolese Hemodialysis Patients: Evaluation of KDIGO Targets

References

• Gutierrez OM, Farwell WR, Kermah D, Taylor EN. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int. 2011;22(6):1745–1753. doi:10.1007/s00198-010-1383-2
   PubMed Web of Science ®Google Scholar
• Malluche HH, Mawad HW, Monier-Faugere MC. Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res. 2011;26(6):1368–1376. doi:10.1002/jbmr.309
   PubMed Web of Science ®Google Scholar
• Brenner M, Hearing V. The Protective Role of Melanin against UV Damage in Human Skin. Photochemistry and Photobiology. 2008;84(3):539–549. doi:10.1111/j.1751-1097.2007.00226.x
   PubMed Web of Science ®Google Scholar
• Prentice A, Schoenmakers I, Jones KS. Vitamin D deficiency and its health consequences in Africa. Clin Rev Bone Mineral Metabol. 2009;7:94–106. doi:10.1007/s12018-009-9038-6
   PubMedGoogle Scholar
• Gupta A, Kallenbach LR, Zasuwa G, Divine GW. Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephrol. 2000;11(2):330–334. doi:10.1681/ASN.V112330
   PubMed Web of Science ®Google Scholar
• Jean G, Chazot C. Complications and therapeutic management of abnormalities phospho-calcium metabolism in chronic renal failure. Néphrol Ther. 2019;15(4):24242–24258.
   Google Scholar
• Mace ML, Olgaard K, Lewin E. New aspects of the kidney in the regulation of FGF-23 and mineral homeostasis. Int J Mol Sci. 2020;21(22):8810. doi:10.3390/ijms21228810
   PubMed Web of Science ®Google Scholar
• Hu MC, Kuro-o M, Moe O. Klotho and chronic kidney disease. Contrib Nephrol. 2013;180:47–63.
   PubMed Web of Science ®Google Scholar
• Fang Y, Ginsberg C, Seifert M, et al. CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder. J Am Soc Nephrol. 2014;25(8):1760–1773. doi:10.1681/ASN.2013080818
   PubMed Web of Science ®Google Scholar
• LaClair RE, Hellman RN, Karp SL, et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis. 2005;45(6):1026–1033. doi:10.1053/j.ajkd.2005.02.029
   PubMed Web of Science ®Google Scholar
• Holick M, Chen T. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080S–1086S. doi:10.1093/ajcn/87.4.1080S
   PubMed Web of Science ®Google Scholar
• Tounkara AA, Coulibaly AM, Coulibaly N, Traoré B, Maiga MK. Management of chronic hemodialysis patients with anemia: case study conducted in the Department of Nephrology and Hemodialysis at the University Hospital Point G in Mali. PAMJ. 2017;26:167. doi:10.11604/pamj.2017.26.167.10861
   Google Scholar
• Bala W, Raquel D, Saraladevi N. Biochemical markers of mineral bone disorder in South African patients on maintenance haemodialysis. Afri Health Sci. 2017;17(2):445–452. doi:10.4314/ahs.v17i2.19
   PubMed Web of Science ®Google Scholar
• Seck SM, Dahaba M, Ka EF, Cisse MM, Gueye S, Tal AOL. Mineral and Bone Disease in Black African Hemodialysis Patients: a report from Senegal. Nephro-Urology. 2012;4(4):613–616.
   Google Scholar
• Cavalier E, Yayo ES, Attoungbre-Hauhouot ML, et al. Vitamin D, bone alkaline phosphatase and parathyroid hormone in healthy subjects and haemodialysed patients from West Africa: impact of reference ranges and parathyroid hormone generation assays on the KDIGO guidelines. Clin Kid J. 2019;12: 2:288–293. doi:10.1093/ckj/sfy074
   Web of Science ®Google Scholar
• Adams J, Hewison M. Update in Vitamin D. J Clin Endocrinob Metab. 2010;95:471–478. doi:10.1210/jc.2009-1773
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1–59. doi:10.1016/j.kisu.2017.04.001
   PubMed Web of Science ®Google Scholar
• Lee SA, Lee MJ, Ryu GW, et al. Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients. Osteoporos Int. 2016;27(9):2717–2726. doi:10.1007/s00198-016-3636-1
   PubMed Web of Science ®Google Scholar
• Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31:607–617. doi:10.1053/ajkd.1998.v31.pm9531176
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int Supplements. 2012;2(4):279–335.
   Google Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 2009;120:1640–1645.
   PubMed Web of Science ®Google Scholar
• Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15(8):2208–2218. doi:10.1097/01.ASN.0000133041.27682.A2
   PubMed Web of Science ®Google Scholar
• Jean G, Souberbielle JC, Chazot C. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation. Nephrol Dial Transpl. 2009;24:3799–3805. doi:10.1093/ndt/gfp370
   PubMed Web of Science ®Google Scholar
• Gupta AK, Jamwal V, P M. Hypervitaminosis D and systemic manifestations: a comprehensive review. JIMSA. 2014;27:236–237.
   Google Scholar
• Tangpricha V, Pearce EN, Chen TC, Holick MF. Vitamin D insufficiency among free living healthy young adults. Am j Med. 2002;112(8):659–662. doi:10.1016/S0002-9343(02)01091-4
   PubMed Web of Science ®Google Scholar
• Ernandez T, Stoermann-Chopard C. Vitamin D and chronic renal failure: renewed interest in a forgotten vitamin. Swiss Med J. 2012;361.
   Google Scholar
• Icardi A, Paoletti E, De Nicola L, Mazzaferro S, Russo R, Cozzolino M. Renal anaemia and EPO hyporesponsiveness associated deficiency: the potential role of inflammation. Nephrol Dial Transplant. 2013;28(7):1672–1679. doi:10.1093/ndt/gft021
   PubMed Web of Science ®Google Scholar
• Noonan ML, Clinkenbeard EL, Ni P, et al. Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD). Physiological Reports. 2020;8:e14434. doi:10.14814/phy2.14434
   PubMed Web of Science ®Google Scholar
• Zhan Z, Smyth B, Toussaint ND, Gray NA, Zuo L, de Zoysa JR. Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study. BMC Nephrol. 2019;20(1):258. doi:10.1186/s12882-019-1438-3
   PubMedGoogle Scholar
• Izeidi PPM, Nlandu YM, Lepira FB, et al. Cost estimate of chronic haemodialysis in Kinshasa, the Democratic Republic of the Congo: a prospective bicentric study. Hemodial Int. 2020;24(1):121–128. doi:10.1111/hdi.12802
   PubMed Web of Science ®Google Scholar